Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Renalytix plc - Sponsored ADR (RNLXY) had Stock-Based Compensation of $0.33M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$11.19M |
|
$0.19M |
|
$0.25M |
|
$11.44M |
|
$4.61M |
|
$8.21M |
|
$8.21M |
|
$12.81M |
|
$-1.37M |
|
$-1.37M |
|
$-1.37M |
|
331.21M |
|
| Cash Flow Statement Financials | |
$-10.33M |
|
$0.02M |
|
$15.04M |
|
$4.68M |
|
$9.21M |
|
$4.53M |
|
|
Stock-Based Compensation |
$0.33M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|